Connect with us

Media OutReach

KGI: 2026 Global Market Outlook

Published

on

Beyond Balance: The Next Regime

HONG KONG SAR – Media OutReach Newswire – 13 January 2026 – Today, KGI has released its 2026 Global Market Outlook, covering markets in the US, Mainland China, Hong Kong, Taiwan, and Singapore.

(From left) James Chu, Chairman at KGI Securities Investment Advisory; James Wey, Head of International Wealth Management at KGI; Cusson Leung, Chief Investment Officer at KGI

After a turbulent year of trade disruptions and policy uncertainty under President Trump, investors face new questions. China has unveiled its 15th Five-Year Plan, as policymakers aim to support domestic growth amid global challenges. The market outlook for 2026 is shaped by interest rate decisions, economic resilience, and shifting international dynamics.

Under this backdrop, we propose the “LEAD” strategy for 2026:

  1. Liquidity Shift
  2. Earnings Focused
  3. Adding Credit
  4. Diversified Assets

Cusson Leung, Chief Investment Officer at KGI, says: “Looking ahead to 2026, investors can adopt a LEAD strategy: L ​​stands for Liquidity Shift, benefiting from a weakening US dollar and interest rate cuts, with funds expected to flow to non-US dollar and Asian currencies; E stands for Earnings Focused, focusing on earnings growth to support valuations and allocating to US, European, and Japanese stocks; A stands for Adding Credit, locking in the credit of leading companies and increasing holdings of A-rated investment grade bonds; and D stands for Diversified Assets, responding to the upward trend in both stocks and bonds by including alternative assets to optimize asset allocation.”

Macro & US Markets
The US economy will experience a more pronounced downturn in 4Q25, which will extend into 1H26, and this will have a negative impact on consumption, slowing investment activity. Nevertheless, AI-driven productivity gains should provide some support, with US GDP growth in 2026 forecast at 2.2%. The eurozone will see moderate growth, with Germany benefiting significantly from fiscal expansion and economic improvement. Japan’s economy will strengthen on domestic demand, aided by additional fiscal stimulus. China has demonstrated resilience under trade protectionism in 2025. With inflation risks easing and labor market risks rising, the US Fed cut the interest rates in September 2025, with a total reduction of 75 bps in 2025, followed by an additional 50-75 bps in 2026.

Regarding US stocks, AI-driven productivity gains and cost reductions should sustain solid profitability, with S&P 500 earnings projected to grow by 13.55% year-on-year (YoY) in 2026. However, higher risk premiums may cap valuation upside, leading us to project a year-end target of 7,650 points. Market performance will reflect risk-driven declines in 1Q26, stabilize and recover in 2Q26, and rally significantly around the midterm elections in 4Q26. By sector, among AI-related themes we favor technology, semiconductors, utilities (on higher power demand), machinery for advanced manufacturing, and industrial REITs. Non-AI beneficiaries include aerospace and defense (on higher military spending), pharmaceuticals (on tariff benefits), and capital market segments (supported by active investment banking). As for fixed income, US economic weakness and Fed rate cuts will drive Treasury yields lower, with 10-year yields expected to fall to 3.5-3.7% by 2Q26. We recommend allocating to US Treasuries or high-rated investment-grade corporate bonds in 1H26, then rotating into high-yield bonds in 2H26 as policy rates and economic conditions reach a bottom.

James Chu, Chairman at KGI Securities Investment Advisory, says: “AI is triggering a new productivity revolution, supporting economic growth and strengthening corporate earnings. While the US economy is expected to slow, a recession remains unlikely, and the short-term impact of tariff policies should gradually fade by the first quarter of 2026. Although the Fed may shift from cutting rates at every meeting to cutting at alternating meetings, the overall environment remains a rate-cutting cycle. In a non-recession backdrop, lower interest rates should continue to support equity market performance.”

Mainland China and Hong Kong Markets
In terms of the macroeconomy, with the conclusion of trade agreements among many countries, risks have subsided. However, due to external drag, China’s GDP growth is expected to slow slightly to 4.6% in 2026. In 2026, investors should focus on four key areas for Hong Kong and mainland China markets: (1) In the consumption sector, domestic demand continued to be the core growth driver, contributing more than half of GDP. As the “trade-in” effect diminishes, the central government is expected to implement the “15th Five-Year Plan” and economic conference plans, launching a new round of subsidies covering culture, entertainment, and sports to continuously boost consumer spending. (2) In the financial market, risk appetite has increased. Given the narrowing spread between bond yields and fixed deposit rates, large amounts of savings are flowing into the capital market seeking returns. The fundamentals of the banking and insurance industries have bottomed out, and the credit structure is accelerating its shift from real estate to supporting the real economy. (3) Regarding the issue of “anti-involution,” the PPI remains weak, and capacity reduction has become a focus. Compared to 2015, this round involves more downstream private enterprises and needs to consider employment, presenting greater challenges. While industry consolidation is expected to be lengthy, the impact is controllable and beneficial for long-term healthy development. (4) Regarding new quality productive forces, this will replace real estate and infrastructure as the main investment focus. Digital infrastructure supports AI and embodied intelligence, and humanoid robots are expected to see commercialization in 2026, “iPhone moment.” Leading companies with core technological autonomy in innovative drugs will enjoy higher valuation premiums.

Overall, we are optimistic on Hang Seng Index. We expect the Federal Reserve’s interest rate cuts to drive fund inflows to the Hong Kong and mainland stock markets. Based on an upward revision of the forward PE ratio to 13.5x and 8% earnings growth, we set a target of 30,000 points for the Hang Seng Index by the end of 2026, representing a potential upside of approximately 14%. As confidence recovers, the investment style is expected to shift from defensive to growth stocks. Recommended 12 stocks: XPeng Motors (9868), UBTECH (9880), Tencent Holdings (700), Alibaba (9988), China Hongqiao (1378), AIA Group (1299), Ping An Insurance (2318), China Merchants Bank (3968), Akeso Biopharma (9926), Pop Mart (9992), Tencent Music (1698), and Sino Land (83).

Cusson Leung, Chief Investment Officer at KGI, says: “2026 marks a crucial turning point for the Chinese economy. While the market anticipates GDP growth to slow to 4.6%, “new quality productive forces,” resembling humanoid robots, is taking over as a new growth engine. The most critical signal in the market is the “awakening” of idle cash—massive savings are flowing from low-interest fixed deposits to the capital market seeking returns. With risk appetite returning and policy support intensifying, now is the time to shift investment strategies from “defensive” to “growth.” Driven by both valuation repair and earnings growth, we are optimistic that the Hang Seng Index will reach 30,000 points, and the allocation value of Hong Kong and mainland China stocks has reappeared.”

Taiwan Market
Compared to the dot-com era bull run, which lasted almost five years, the current AI frenzy has been around for about three years, suggesting that the uptrend is still in its middle phase and could extend through 2026.

AI plays are trading at high PEs, such valuations are backed by strong fundamentals. In fact, the PEG ratio of Taiwan’s AI supply chain has yet to surpass 1x. We estimate that aggregate earnings of AI plays will grow by 21% YoY in 2026, following impressive upticks of 35% in 2024 and 43% in 2025. AI stocks now account for more than 60% of TAIEX earnings, and with the ongoing AI arms race, overall TAIEX earnings growth is projected to accelerate from 14% in 2025F to 20% in 2026.

Although the AI frenzy should keep the bull market intact, volatility will rise in tandem due to: (1) substantial cumulative gains, and the fact that valuations are approaching historic highs; (2) policy and political uncertainty surrounding the US midterm elections; and (3) potential changes in the US Fed’s rate-cut pace. We expect the TAIEX to repeat a “smile-curve” pattern, featuring continued strength in 1Q26, followed by healthy corrections in 2Q-3Q26 before closing the year with a renewed upswing.

We think investors need to pay attention to two major themes. The first is a broad-based product spec upgrade trend across the AI supply chain, which will drive the industry into a new growth phase, with beneficiaries including foundries, GPU and ASIC designers, advanced packaging (such as CoWoS), and ODMs, as well as testing interfaces, memory, thermal solutions, CCL, ABF substrates, PCBs, switches, and power component suppliers amid strong AI computing demand and ongoing GPU platform upgrades. The second is diversification and defensive asset allocation. Innovations in consumer electronics, such as foldable iPhones and smart wearables, will provide growth opportunities, while companies with resilient domestic demand and stable high dividend yields offer a balanced strategy combining growth and income. Overall, investors should strike a balance between growth and resilience against volatility in their portfolios, in the face of market fluctuations.

James Chu, Chairman at KGI Securities Investment Advisory, says: “The solid earnings growth driven by AI and still reasonable valuations form a strong foundation for the ongoing bull market in Taiwanese equities. With AI adoption accelerating across enterprises and consumers, demand for computing power is rising rapidly. Yet supply remains constrained by chip and power bottlenecks, meaning hardware suppliers are likely to face continued shortages through 2026. Taiwan’s AI supply chain is set to remain a key beneficiary, particularly those tied to next-generation specification upgrades.”

Singapore Market
In 9M25, the overall performance of Singapore’s economy was better than expected as the global trade tensions eased after the US pivoted on its reciprocal tariffs and reached deals with its major trading partners. The manufacturing, wholesale trade and finance & insurance sectors remained the growth pillars of the Singapore economy, and each sector delivered decent growth. In particular, manufacturing’s growth has been robust, driven by the electronics, transport engineering and biomedical manufacturing clusters. The full year outlook is upbeat, as the growth momentum shall continue till the end of the year.

Looking ahead, the global economic outlook for 2026 suggests slower GDP growth for most of Singapore’s key trading partners, including China and the Eurozone, largely due to the impact of US tariffs, which will temper demand for Southeast Asian exports, though US growth is expected to remain resilient from AI investment. Consequently, Singapore’s outward-oriented sectors, particularly manufacturing and trade-related services, are projected to expand at a slower pace than in 2025, although the electronics and related sectors will benefit from AI demand, while some precision engineering and biomedical output may moderate domestically, the construction sector is set to grow, but consumer-facing sectors are likely to remain subdued. However, the relatively low interest rates and continuous government support shall buffer the impact of the slowdown, and the capital market will still benefit from the upward re-rating catalysts.

Chen Guangzhi, Head of Research at KGI Singapore, says: “Thanks to trade de-escalation and the AI wave, Singapore experienced significant economic expansion in 2025. Proactive government initiatives turbo-charged the equity bull run, and this strong momentum is expected to deliver an optimistic economic outlook for 2026.”
Hashtag: #KGI #MarketOutlook




Wechat: KGI 凱基

The issuer is solely responsible for the content of this announcement.

KGI

KGI* has been a leading financial institution in Asia since 1997. Our scope of business encompasses wealth management, brokerage, fixed income, and asset management. We are committed to offering a comprehensive range of financial products and services to corporate, institutional, and individual clients throughout Asia. Backed by KGI Financial Group, we have a robust footprint in Asia, covering Taiwan, Hong Kong, Singapore, Indonesia, and Thailand^.

*KGI refers to KGI Asia Limited and its affiliates.
^an investee enterprise of KGI Securities, not a subsidiary.

DISCLAIMER
All the information contained in this document is not intended for use by persons or entities located in or residing in jurisdictions which restrict the distribution of this document by KGI Asia Limited (“KGI”), or any other affiliates of KGI. Such information shall not constitute investment advice, or an offer to sell, or an invitation, solicitation or recommendation to subscribe for or invest in any securities, insurance or other investment products or services nor a distribution of information for any such purpose in any jurisdiction. In particular, the information herein is not for distribution and does not constitute an offer to sell or the solicitation of any offer to buy any securities in the United States of America, or to or for the benefit of United States persons (being residents of the United States of America or partnerships or corporations organised under the laws of the United States of America or any state, territory or possession thereof). All the information contained in this document is for general information and reference purpose only without taking into account of any particular investor’s objectives, financial situation or needs and may not be redistributed, reproduced or published (in whole or in part) by any means or for any purpose without the prior written consent of KGI. Such information is not intended to provide any legal, financial, tax or other professional advice and should not be relied upon in that regard.
All investments involve risks. The prices of securities fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities.
Bond investment is NOT equivalent to a time deposit. It is NOT protected under the Hong Kong Deposit Protection Scheme. Bondholders are exposed to a variety of risks, including but not limited to: (i) Credit risk – The issuer is responsible for payment of interest and repayment of principal of bonds. If the issuer defaults, the holder of bonds may not be able to receive interest and get back the principal. It should also be noted that credit ratings assigned by credit rating agencies do not guarantee the creditworthiness of the issuer; (ii) Liquidity risk – some bonds may not have active secondary markets and it would be difficult or impossible for investors to sell the bond before its maturity; (iii) Interest rate risk – When the interest rate rises, the price of a fixed rate bond will normally drop, and vice versa. If you want to sell your bond before it matures, you may get less than your purchase price. Do not invest in bond unless you fully understand and are willing to assume the risks associated with it. Please seek independent advice if you are unsure.
You are advised to exercise caution and undertake your own independent review, and you should seek independent professional advice before making any investment decision. You should carefully consider whether investment is suitable in light of your own risk tolerance, financial situation, investment experience, investment objectives, investment horizon and investment knowledge.
No representation or warranty is given, whether express or implied, on the accuracy, adequacy or completeness of information provided herein. In all cases, anyone proposing to rely on or use the information contained herein should independently verify and check the accuracy, completeness, reliability and suitability of the information. Simulations, past and projected performance may not necessarily be indicative of future results.
Information including the figures stated herein may not necessarily have been independently verified, and such information should not be relied upon in making investment decisions. None of KGI, its affiliates or their respective directors, officers, employees and representatives will be liable for any loss or damage of any kind (whether direct, indirect or consequential losses or other economic loss of any kind) suffered or incurred by any person or entity due to any omission, error, inaccuracy, incompleteness or otherwise, or any reliance on such information. Furthermore, none of KGI, its affiliates or their respective directors, officers, employees and representatives shall be liable for the content of information provided by or quoted from third parties.
Members of the KGI group and their affiliates may provide services to any companies and affiliates of such companies mentioned herein. Members of the KGI group, their affiliates and their directors, officers, employees and representatives may from time to time have a position in any securities mentioned herein.

Advertisement

Media OutReach

EtonHouse Rolls Out Enterprise AI Workspace with OpenAI, Aligning Education with Singapore’s National AI Push

Published

on

SINGAPORE – Media OutReach Newswire – 24 February 2026 – In the wake of Budget 2026 and Prime Minister Lawrence Wong’s announcement of a National AI Council to accelerate mission-driven artificial intelligence deployment, EtonHouse International Education Group has collaborated with OpenAI to roll out ChatGPT Edu across its global education network, establishing a secure, enterprise-grade AI workspace designed to strengthen governance, operational excellence and institutional capability.

Students of EtonHouse using a computer

The implementation spans the Group’s schools and education brands, including EBridge Pre-School, an Anchor Operator, extending AI integration beyond classroom experimentation into enterprise-wide infrastructure supporting operations, marketing and admissions, finance, human resources, school administration and technology development.

While education was not named among the initial priority sectors identified under Singapore’s national AI strategy, EtonHouse views schools as foundational to building long-term AI capability and literacy across society.

Governance-led AI deployment

The rollout has been structured around enterprise governance principles. Access is managed through role-based access controls, single sign-on authentication and automated provisioning, ensuring that AI tools and information remain aligned to defined job responsibilities and permission boundaries.

ChatGPT Edu operates within a centrally managed internal workspace governed by consistent policies across the Group. External sharing and third-party integrations are enabled only where explicitly approved and aligned with business requirements, reinforcing a secure and compliant AI environment.

This governance-first approach reflects a deliberate shift from isolated experimentation to structured, scalable adoption.

From classroom innovation to enterprise infrastructure

EtonHouse previously developed Lumina, its proprietary AI-powered lesson planning platform. The deployment of ChatGPT Edu represents the next phase of integration, extending advanced artificial intelligence capabilities into enterprise functions.

Within the secure workspace, teams can upload documents for structured analysis, generate comparative reports, conduct scenario modelling and retrieve institutional knowledge more efficiently. Technology teams are also leveraging Codex, OpenAI’s agentic coding tool, to enhance development workflows, supporting code drafting, review and testing while maintaining human oversight and established engineering standards.

The Group is concurrently developing internal AI assistants and structured workflows within defined governance parameters to streamline routine processes and standardise how knowledge is accessed and applied across departments.

Augmentation, not replacement

EtonHouse emphasises that artificial intelligence is being implemented as an augmentation layer rather than a substitute for professional judgement.

“Artificial intelligence is not a shortcut or a replacement technology. It is a learning infrastructure,” said Mr Ng Yi-Xian, Group CEO of EtonHouse International Education Group. “We are developing tools that help students learn more confidently, support teachers to plan and differentiate more effectively, and equip HQ teams to serve schools faster and with higher quality. AI should amplify good practice, not replace it, so we are building the governance and capability to deploy it responsibly at scale.”

The rollout will be supported by structured staff training alongside OpenAI experts clear usage guidelines and ongoing oversight to ensure transparency, responsible usage and alignment with internal policies and regulatory obligations.

“As Singapore advances its national AI ambitions, many institutions are working to bridge the gap between rapidly advancing AI technologies and their ability to deploy them effectively and responsibly. EtonHouse’s rollout of ChatGPT Edu shows how forward-thinking education organisations can translate AI into practical, trusted enterprise-wide systems that empower teams today, while building confidence for the long-term.” added Oliver Jay, Managing Director, International at OpenAI.

Education’s role in Singapore’s AI future

Budget 2026 outlined the formation of a National AI Council to guide coordinated deployment across priority sectors including advanced manufacturing, connectivity, finance and healthcare.

EtonHouse’s implementation reflects how education institutions can apply similar principles of governance, security and enterprise readiness, positioning schools not only as adopters of technology but as contributors to Singapore’s broader AI capability building.

With this move, EtonHouse signals a transition from exploratory AI usage to secure, scalable integration across its global network, reinforcing its commitment to innovation anchored in institutional discipline and responsible deployment.

Hashtag: #ArtificialIntelligence #EnterpriseAI #AIGovernance #AIDeployment #EdTech





The issuer is solely responsible for the content of this announcement.

About EtonHouse International Education Group

Founded in 1995 in Singapore, EtonHouse has grown into a global education group with more than 100 schools across eight countries. The Group offers a highly recognised international education pathway from infant care to high school, including the International Baccalaureate, Cambridge, and the Reggio Emilia-inspired approach, all designed to nurture inquiry, creativity, and intercultural understanding. Beyond schools, EtonHouse is deeply committed to community impact through teacher training, philanthropy, and purpose-driven educational initiatives.

Its commitment to excellence has earned the Group numerous accolades, including:

  • E-Bridge successfully earned multiple accolades for teaching excellence and innovation from the ECDA Awards for Excellence in Early Childhood Development from 2019-2024.
  • E-Bridge Pre-School Bukit Panjang clinched the “Outstanding Centre for Teaching and Learning Award” in 2019.
  • E-Bridge educators were commended with “Outstanding Early Childhood Teacher Award” in 2021.
  • Clinched “Promising Infant Educator Award & Early Childhood Innovation Award” in 2022.
  • E-Bridge Pre-School SengKang Square won the “Outstanding Centre for Teaching and Learning Award” in 2023.
  • Clinched the “Outstanding Centre for Teaching and Learning Award” for E-Bridge Pre-School Sengkang Square and “Outstanding Early Intervention Professional” in 2024.
  • EtonHouse International School Suzhou, an IB K-12 school, garnered recognition as one of China’s top international schools, according to a research firm based in Washington, DC.
  • In 2023, EtonHouse China won the ‘Forbes China Best International Education Group Award.’
  • In 2024, EtonHouse received the esteemed HoneyKids Singapore Education Awards, achieving Gold for “Best Bilingual Programme”, Silver for “Best Small School in Singapore” and clinched both Gold and Silver for “Principal of the Year (Kindergarten).
  • In 2025, EtonHouse launched two news campuses in Saudi Arabia, EtonHouse International Pre-School Granada and EtonHouse International School Granada while achieving 6 HoneyKids Singapore Education Awards in Singapore.

At EtonHouse, collaboration with governments is a cornerstone of its mission. The partnerships include:

  • Participation in Singapore’s Anchor Operator (AOP) Scheme, launching E-Bridge Pre-School in 2014 to deliver top-notch infant care and pre-school education for children aged 2 months to 6 years across a network of 31 centres.
  • The expansion of EtonHouse’s presence in Suzhou and Nanjing, China came at the invitation of the Jiangsu provincial government, reinforcing its commitment to global education.
  • Won an Economic Development Board tender in 2017 and introduced Middleton International School, offering an affordable schooling option for expatriate families.

In 2015, the EtonHouse Community Fund (ECF) was established, dedicated to enhancing the lives of underserved children and youth through education.

The Eton Academy was launched in 2020, providing English, Maths, and Science academic programmes for Nursery 1 to Primary 6 in centres across the island. Building on this success, The Eton Academy expanded in 2025 with the introduction of Elevate After School Care, offering primary school children a holistic, well-rounded after-school experience that complements their academic development.

EtonHouse International Education Group remains unwavering in its commitment to shaping futures and making a meaningful impact on the world through education.

Continue Reading

Media OutReach

Triple agonist UBT251 delivers up to 19.7% mean weight loss after 24 weeks in phase 2 trial in China

Published

on

  • UBT251 is a triple agonist of the receptors for GLP-1, GIP and glucagon (triple G), being jointly developed by United Biotechnology and Novo Nordisk
  • In a placebo-controlled phase 2 trial in Chinese people with overweight or obesity, UBT251 led to a statistically significant mean weight loss of up to 19.7% after 24 weeks
  • UBT251 appeared to have a safe and well-tolerated profile consistent with incretin-based therapies.

GUANGDONG, CHINA & BAGSVÆRD, DENMARK – Media OutReach Newswire – 24 February 2026 – The United Laboratories International Holdings Limited (TUL) and Novo Nordisk A/S (Novo Nordisk) today announced topline results from a Chinese phase 2 trial of UBT251, a triple agonist of the receptors for GLP-1, GIP, and glucagon (triple G).

UBT251 is being jointly developed by TUL’s wholly-owned subsidiary The United Bio-Technology (Hengqin) Co., Ltd. (United Biotechnology) and Novo Nordisk under an agreement signed in March 2025. United Biotechnology is responsible for development in Chinese mainland, Hong Kong, Macau and Taiwan, while Novo Nordisk is responsible for development in the rest of the world.

The trial, conducted by United Biotechnology, investigated the safety and efficacy of once-weekly injectable 2 mg, 4 mg and 6 mg doses of UBT251 compared to placebo in Chinese people with overweight or obesity. From a baseline mean body weight of 92.2 kg, the highest mean weight loss observed for people treated with UBT251 was 19.7% (-17.5 kg) compared to 2.0% (-1.6kg) in the placebo group after 24 weeks of treatment[i].

Moreover, all dose groups of UBT251 showed statistically significant improvements relative to placebo on key secondary endpoints, including waist circumference, blood glucose, blood pressure and lipids.

In the trial, UBT251 appeared to have a safe and well-tolerated profile. The most common adverse events were gastrointestinal, and the vast majority were mild to moderate and diminished over time, consistent with incretin-based therapies.

“The success of the phase 2 clinical trial of UBT251 in China represents another significant milestone in TUL’s innovation-driven development,” said Mr Tsoi Hoi Shan, Chairman of TUL. “We will continue to focus on chronic diseases, including endocrine and metabolic disorders, accelerate the further development of UBT251, and strive to bring more high-quality treatment options to patients worldwide at the earliest opportunity.”

“We are very encouraged by these data from the trial in China, which demonstrate the potential of UBT251 and its differentiated clinical profile and safety and tolerability profile,” said Martin Holst Lange, executive vice president, chief scientific officer and head of Research and Development at Novo Nordisk. “We look forward to reporting data from a global trial with UBT251 conducted by Novo Nordisk next year.”

Novo Nordisk recently initiated a global phase 1b/2a trial investigating the safety, tolerability, pharmacokinetics and pharmacodynamics of different doses of UBT251 for up to 28 weeks in around 330 people living with overweight or obesity. Topline data from that trial is expected in 2027. Novo Nordisk also expects to initiate a phase 2 trial with UBT251 in people with type 2 diabetes in the second half of 2026.

United Biotechnology will present detailed data from the Chinese phase 2 trial at a medical congress later this year. Based on the results of this trial, the company is planning to initiate a phase 3 trial in Chinese patients with overweight or obesity.

About the Chinese phase 2 trial

This randomized, double-blind, placebo-controlled trial enrolled a total of 205 Chinese patients with obesity (BMI ≥ 28.0 kg/m²) or overweight (24.0 kg/m² ≤ BMI < 28.0 kg/m²) with at least one weight-related comorbidity. The baseline mean body weight of the patients was 92.2 kg, with a baseline mean BMI of 33.1 kg/m².

Patients were randomly assigned to receive weekly subcutaneous injections of UBT251 in doses of 2 mg, 4 mg, 6 mg, or placebo for 24 weeks.

The primary endpoint of the trial was the percentage change in body weight from baseline after 24 weeks of treatment.

About UBT251

UBT251 is a long-acting synthetic peptide triple agonist targeting the receptors for GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide) and glucagon.

In March 2025, United Biotechnology entered an exclusive license agreement with Novo Nordisk A/S for UBT251. Under the agreement, Novo Nordisk obtained exclusive worldwide rights (excluding Chinese mainland, Hong Kong, Macau, and Taiwan) to develop, manufacture and commercialise UBT251. United Biotechnology retained the rights for UBT251 in Chinese mainland, Hong Kong, Macau and Taiwan.


[i] Based on the efficacy estimand according to the trial protocol, regardless of dose modification

Hashtag: #UBT251

The issuer is solely responsible for the content of this announcement.

About TUL and United Biotechnology

Founded in 1990, TUL (HKEX: 3933) is mainly engaged in the research and development, production and sales of pharmaceuticals, and ranks among the leading integrated pharmaceutical companies in China. TUL currently boasts seven production bases, covering intermediate products, bulk medicine, finished products, veterinary drugs, empty capsule casings, and medical devices, with the sales networks dotted across nearly 80 countries and regions. United Biotechnology, located in the Guangdong-Macao In-Depth Cooperation Zone in Hengqin, serves as the biopharmaceutical R&D headquarter of TUL. United Biotechnology focuses on the development of high-end biopharmaceuticals to treat major chronic diseases. For more information, please visit .

About Novo Nordisk

Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat serious chronic diseases, built upon our heritage in diabetes. We do so by pioneering scientific breakthroughs, expanding access to our medicines, and working to prevent and ultimately cure disease. Novo Nordisk employs about 68,800 people in 80 countries and markets its products in around 170 countries. For more information, visit , .

Continue Reading

Media OutReach

Hong Kong Tech Delegation Heading for Market Expansion at Mobile World Congress 2026

Published

on

Debut at startup-centric zone 4YFN, Dual-presence at World Class Tech Exhibitions in Spain

HONG KONG SAR – Media OutReach Newswire – 24 February 2026 – Hong Kong Science and Technology Parks Corporation (HKSTP), in collaboration with Hong Kong Trade Development Council (HKTDC), will lead a delegation of 21 Hong Kong tech companies and institutions to showcase at Mobile World Congress (MWC) 2026—the world’s premier connectivity event, and debut at 4 Years From Now (4YFN) 2026—a global stage for start-ups, taking place concurrently 2-5 March in Barcelona, Spain.

Building on the momentum from MWC 2025—the Delegation will be featuring solutions beyond the Connectivity category, covering focus areas across Devices and Systems, Digital Transformation and support from Ecosystem Partners. The Pavilion duet ought to give a more comprehensive picture of Hong Kong’s innovation and technology (I&T) capabilities in engaging global telecom leaders, enterprise decision-makers, industry partners, and investors, bridging cutting-edge research and development (R&D) into real-world applications and propelling Hong Kong’s I&T sector onto the international stage.

Derek Chim, Head of Startup Ecosystem and Development, HKSTP said, “MWC is a global bellwether for communications technology and tech companies at any stage, to connect with the industry and investors, to have a solid ground that validate solutions, catalyse pilot projects, accelerate commercialisation, and scale internationally.”

Iris Wong, Director, Merchandise Trade and Innovation / Director, External Relations, HKTDC, said, “The Hong Kong Tech Pavilion is an ideal platform for Hong Kong tech enterprises to present their latest R&D achievements at major international tech gatherings, support their journey to explore overseas markets, while highlighting Hong Kong’s strengths as an international innovation and technology hub.”

A series of dialogues and exchanges, spanning from networking reception and themed talks to pitching sessions, will take place throughout the events at the Pavilion to facilitate partnerships and investment opportunities for innovative solutions that are market-ready with high potential for market expansion, in particular, Asmote and Cresento under “Connectivity” make stellar examples of the notion:

  • 5G & 6G for Communication, Sensing, and AI computingShannon & Turing, (Asmote), located at MWC, specialises in mmWave technology for Integrated Sensing and Communication (ISAC) technology—drone communications and control—rising to the occasion as the city advances its low-altitude economy initiatives, while winning favors for its efficiency in managing industrial scenarios such as smart ports and dark factories. The company previously secured the world’s first 26GHz mmWave 5G commercial communications project, demonstrating its leadership in industrial-grade applications.
  • Smart Performance Insights for Sport Cresento, located at 4YFN, focused on developing an AI-powered shin guard to deliver real-time insights—performance analytics, team leaderboards, and more—with a design that incorporates into gears that athletes already wear and creates minimal friction for, in particular, football players to adapt, will be moving from prototypes to pilot collaborations with European football clubs, academies and sport tech platforms and distributors.

HKSTP continues to join hands with HKTDC to support Hong Kong tech enterprises to “go global” by jointly organising the Hong Kong Tech Pavilion to build bridges linking tech companies with the world. This expedites the industry’s progress in internationalisation to meet the growing demand for I&T globally. This will attract talents, facilitate forward-looking investments and explore opportunities globally, realising the mission of entrepreneurs to reach out to the world and further consolidate Hong Kong’s position as an international I&T hub.

Mobile World Congress Barcelona (MWC) & 4 Years From Now (4YFN)
Date: 2-5 March 2026
Venue: Fira Gran Via, Av. Joan Carles I, 64, 08908 L’Hospitalet de Llobregat, Barcelona, Spain

Hong Kong Tech Pavilion:
MWC – Booth 6E44 at Hall 6
4YFN – Booth 8.1B31 at Hall 8.1

Please visit https://bit.ly/MWC2026HKTech for more information on Hong Kong Tech Pavilion and the exhibitors.

Appendix: Full list of 21 tech entities showcasing at Hong Kong Tech Pavilion during MWC and 4YFN 2026 (in alphabetical order)

No. Name of Tech Company / Institution Category
MWC 2026 – Booth 6E44 at Hall 6
1 Entoptica Limited Devices & Systems
2 eSIX Connectivity
3 Faraconix Technologies Co., Ltd. Connectivity
4 FreightAmigo Services Limited Digital Transformation
5 Glassdio Scientific Company Limited Connectivity
6 Harvest Elite International Limited Digital Transformation
7 HongKong Umedia Limited Devices & Systems
8 iASPEC Services Limited Digital Transformation
9 InvestHK Ecosystem Partners
10 Robocore Technology Limited Devices & Systems
11 Shannon & Turing Technology Limited Connectivity
12 The Hong Kong Polytechnic University Ecosystem Partners
13 Xeroptix Technology Devices & Systems
4YFN 2026 – Booth 8.1B31 at Hall 8.1
14 AIGM Limited Digital Transformation
15 BWSea Technology (HK) Co., Limited Digital Transformation
16 Cresento Limited Devices & Systems
17 GoGoChart Technology Limited Digital Transformation
18 HairCoSys Limited Devices & Systems
19 KNQ Technology Limited Digital Transformation
20 Solos Technology Limited Devices & Systems
21 Vista Innotech Limited Devices & Systems

Hashtag: #HKSTP

The issuer is solely responsible for the content of this announcement.

HKSTP

More information about HKSTP is available at

Continue Reading

Trending